A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes

Diabetes

Volumn 51, Issue 4, 2002, Pages 1208-1213

  Hokanson, John E ^a   Cheng, Suzanne ^b   Snell Bergeon, Janet K ^a   Fijal, Bonnie A ^b   Grow, Michael A ^b   Hung, Chi ^b   Erlich, Henry A ^b   Ehrlich, James ^c   Eckel, Robert H ^a   Rewers, Marian ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c Division of Endocrinology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER TRIACYLGLYCEROL LIPASE;

ADULT; ARTERY CALCIFICATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTRON BEAM TOMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR;

EID: 0036228585     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.4.1208     Document Type: Article

References (50)

1. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus
2. The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification
3. Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus
4. Coronary artery disease in IDDM: Gender differences in risk factors but not risk
5. Cardiovascular disease in insulin dependent diabetes mellitus: Similar rates but different risk factors in the US compared with Europe
6. Coronary calcium in adults with type 1 diabetes: A stronger correlate of clinical coronary artery disease in men than in women
7. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study
8. Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: Interrelations and risk factor profiles: Pittsburgh Epidemiology of Diabetes Complications Study-V
9. Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy
10. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy
11. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus
12. Electron beam computed tomography and coronary artery disease: Scanning for coronary artery calcification
13. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study
14. Coronary artery calcium in acute coronary syndromes: A comparative study of electron-beam computed tomography, coronary angiography, and intracoronary ultrasound in survivors of acute myocardial infarction and unstable angina
15. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: Relation to age and risk factors
16. American College of Cardiology/American Heart Association Expert Consensus document on electron beam computed tomography for the diagnosis and prognosis of coronary artery disease
17. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography
18. Prediction of coronary events with electron beam computed tomography
19. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography
20. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events
21. Common C-to-T substitution at position 480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients
22. Hepatic lipase activity is lower in African American men than in white American men: Effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC)
23. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol
24. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease: Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations
25. Promoter polymorphisms of hepatic lipase gene influence HDL(2) but not HDL(3) in African American men: CARDIA study
26. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study
27. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women
28. Hepatic lipase: New insights from genetic and metabolic studies
29. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol
30. A multilocus genotyping assay for cardiovascular disease
31. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis
32. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: The role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans
33. In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity
34. Ischemic heart disease, atherosclerosis, and longevity
35. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men
36. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease
37. Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis
38. Progression and regression of human coronary atherosclerosis: The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth
39. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia
40. Evidence for a new pathophysiological mechanism for coronary artery disease regression: Hepatic lipase-mediated changes in LDL density
41. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene: The LOCAT Study investigators
42. Hepatic lipase promoter SNPs associated with increased HDL cholesterol and paradoxically an increased risk of ischemic heart disease: The Copenhagen City Heart Study
43. The hepatic lipase promoter polymorphism is associated with an increase in coronary disease
44. Low hepatic lipase activity is a novel risk factor for coronary artery disease
45. Hepatic lipase gene variation is related to coronary reactivity in healthy young men
46. Coronary flow reserve in young men with familial combined hyperlipidemia
47. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment
48. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity
49. Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene
50. Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by upstream stimulatory factor